Xelios Biometrics and ScriptPro are pleased to announce that they have entered into a multi- year licensing agreement whereby Xelios will supply biometric authentication technology to be used in ScriptPro’s pharmacy automation and management systems.
According to Mike Coughlin, ScriptPro’s President and CEO, “We believe that biometric authentication is the simplest and most powerful way to implement controls over pharmacy processes. We have tested a number of these technologies and believe that Xelios has taken this method to a new level of speed and accuracy.”
Xelios Biometrics is a leading creator and supplier of biometric identity solutions based on the technology originally developed by Safran (SAF.PA) for police and military. The Xelios technology has been integrated into tailor-made solutions for various industries including banking, healthcare and stadiums. Customers around the world rely on Xelios solutions for identity authentication, fraud prevention and securing access to facilities and information networks.
Nota de prensa en REUTERS
Nota de prensa en Drug Store News